Advertisement
U.S. markets open in 2 hours 5 minutes
S&P Futures
6,030.75 -7.50 (-0.12%) Dow Futures
44,962.00 +11.00 (+0.02%) Nasdaq Futures
20,931.00 -62.50 (-0.30%) Russell 2000 Futures
2,450.60 +18.20 (+0.75%) Crude Oil
69.02 +0.25 (+0.36%) Gold
2,678.60 +32.30 (+1.22%)
Emergent BioSolutions Inc. (EBS)
NYSE - Nasdaq Real Time Price. Currency in USD
Follow
At close: 04:00PM EST
Pre-Market:
| Previous Close | 9.85 |
| Open | 9.80 |
| Bid | 0.00 x 1300 |
| Ask | 0.00 x 1100 |
| Day's Range | 9.56 - 10.07 |
| 52 Week Range | 1.42 - 15.10 |
| Volume | |
| Avg. Volume | 1,877,214 |
| Market Cap | 543.468M |
| Beta (5Y Monthly) | 1.57 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -3.91 |
| Earnings Date | Nov 06, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 12.00 |
Simply Wall St.Emergent BioSolutions Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
Emergent BioSolutions ( NYSE:EBS ) Third Quarter 2024 Results Key Financial Results Revenue: US$293.8m (up 8.6% from 3Q...
GuruFocus.comEmergent BioSolutions Inc (EBS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ...
Emergent BioSolutions Inc (EBS) reports a robust financial performance with a 9% revenue increase and significant debt reduction, despite challenges in Narcan sales.
Advertisement
Advertisement
Advertisement
© 2024 Yahoo. All rights reserved.